Your browser doesn't support javascript.
loading
Phase 2 study of preoperative chemotherapy with nab-paclitaxel and gemcitabine followed by chemoradiation for borderline resectable or node-positive pancreatic ductal adenocarcinoma.
Chen, Emerson Y; Kardosh, Adel; Nabavizadeh, Nima; Foster, Bryan; Mayo, Skye C; Billingsley, Kevin G; Gilbert, Erin W; Lanciault, Christian; Grossberg, Aaron; Bensch, Kenneth G; Maynard, Erin; Anderson, Eric C; Sheppard, Brett C; Thomas, Charles R; Lopez, Charles D; Vaccaro, Gina M.
Afiliación
  • Chen EY; Division of Hematology and Medical Oncology, Oregon Health & Science University, Knight Cancer Institute, Portland, Oregon, USA.
  • Kardosh A; Division of Hematology and Medical Oncology, Oregon Health & Science University, Knight Cancer Institute, Portland, Oregon, USA.
  • Nabavizadeh N; Department of Radiation Medicine, Oregon Health & Science University, Portland, Oregon, USA.
  • Foster B; Department of Diagnostic Radiology, Oregon Health & Science University, Portland, Oregon, USA.
  • Mayo SC; Division of Surgical Oncology, Oregon Health & Science University, Knight Cancer Institute, Portland, Oregon, USA.
  • Billingsley KG; Yale Cancer Center, New Haven, Connecticut, USA.
  • Gilbert EW; Division of Gastrointestinal and General Surgery, Oregon Health & Science University, Portland, Oregon, USA.
  • Lanciault C; Providence Cancer Institute, Portland, Oregon, USA.
  • Grossberg A; Department of Radiation Medicine, Oregon Health & Science University, Portland, Oregon, USA.
  • Bensch KG; Portland VA Medical Center, Portland, Oregon, USA.
  • Maynard E; Portland VA Medical Center, Portland, Oregon, USA.
  • Anderson EC; Division of Hematology and Medical Oncology, Oregon Health & Science University, Knight Cancer Institute, Portland, Oregon, USA.
  • Sheppard BC; Division of Gastrointestinal and General Surgery, Oregon Health & Science University, Portland, Oregon, USA.
  • Thomas CR; Department of Radiation Medicine, Oregon Health & Science University, Portland, Oregon, USA.
  • Lopez CD; Radiation Oncology, Geisel School of Medicine at Dartmouth and Dartmouth Cancer Center, New Hampshire, Lebanon, USA.
  • Vaccaro GM; Division of Hematology and Medical Oncology, Oregon Health & Science University, Knight Cancer Institute, Portland, Oregon, USA.
Cancer Med ; 12(12): 12986-12995, 2023 06.
Article en En | MEDLINE | ID: mdl-37132281
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Adenocarcinoma / Carcinoma Ductal Pancreático / Neutropenia Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Cancer Med Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Adenocarcinoma / Carcinoma Ductal Pancreático / Neutropenia Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Cancer Med Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos